Athens Research/Cambio - Excellence in Molecular Biology/Bordetella pertussis/52-5571

价格
面议
货号:52-5571
浏览量:82
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cell culture contamination control

Cell culture contamination control: Detection

Detection and identification of Mycoplasma

  • Catalogue
  • Description
  • Protocols
  • References
  • Applications & Benefits

Venor® PCR Quantification Standards

Venor® Quantification Standards for Mycoplasma Detection from Minerva

Minerva Biolabs

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
52-0071Pseudomonas aeruginosaPseudomonas aeruginosa£239.00QuantityAdd to Order
52-0083Escherichia colieach£239.00QuantityAdd to Order
52-0101Legionella pneumophila£239.00QuantityAdd to Order
52-0112Mycoplasma orale£239.00QuantityAdd to Order
52-0115Mycoplasma gallisepticumMycoplasma gallisepticum£239.00QuantityAdd to Order
52-0116Acholeplasma laidlawii£239.00QuantityAdd to Order
52-0117Mycoplasma fermentans£239.00QuantityAdd to Order
52-0119Mycoplasma pneumoniae£239.00QuantityAdd to Order
52-0124Mycoplasma synoviaeMycoplasma synoviae£239.00QuantityAdd to Order
52-0129Mycoplasma argininiMycoplasma arginini£239.00QuantityAdd to Order
52-0130Mycoplasma hyorhinis£239.00QuantityAdd to Order
52-0164Spiroplasma citriSpiroplasma citri£239.00QuantityAdd to Order
52-5571Bordetella pertussisBordetella pertussis£239.00QuantityAdd to Order

Venor® PCR Quantification Standards

Venor® Quantification Standards for Mycoplasma Detection from Minerva

Minerva Biolabs

The quantification standard is genomic DNA extracted from low passage and defined mycoplasma or legionella cultivated in liquid medium according to the European Pharmacopoeia or in Hayflick"s medium. The extraction of the DNA is done by column absorption methods and the DNA purified by phenol/chloroform extraction and ethanol precipitation. The concentration was determined photometrically and by real-time PCR. The DNA concentration was adjusted by dilution with DNA stabilizing buffer. Genomic DNA is used as a control template when DNA amplification tests by conventional PCR are performed (e.g. as contamination control in cell culturing). With the real-time PCR technology, this titrated DNA standard with a defined concentration of genome copies is used as calibrator to generate standard curves. Therefore the provided solution is diluted in a 10x dilution series with DNA-free water and used as a PCR sample. With the generated fluorescent data, the software provided with the real-time PCR instrument calculates a standard curve, which can be used to determine the DNA concentration of unknown samples.

Contents

1 vial (green cap) of Standard DNA, 100 µl, contains approx. 106 genomes/µl.3 vials (white cap) with 1 ml of DNA free water.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor® PCR Quantification Standards

Venor® Quantification Standards for Mycoplasma Detection from Minerva

Minerva Biolabs

Protocols

Legionella pneumophila
http://www.minerva-biolabs.com/download/manuals/VQS_101_Leg.pneumophila_1007.pdf
Mycoplasma synoviae
http://www.minerva-biolabs.com/download/manuals/VQS_M-synoviae_0410.pdf
Mycoplasma orale
http://www.minerva-biolabs.com/download/manuals/VQS_112_M.orale_1007.pdf
Mycoplasma pneumoniae
http://www.minerva-biolabs.com/download/manuals/VQS_119_M.pneumoniae_0809.pdf
Acholeplasma laidlawii
http://www.minerva-biolabs.com/download/manuals/VQS_52-0116_A-laidlawii_0409.pdf
Please note: all protocols off site are the responsibility of the products supplier

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor® PCR Quantification Standards

Venor® Quantification Standards for Mycoplasma Detection from Minerva

Minerva Biolabs

Dumke R. et al., (2017). Multi-center evaluation of one commercial and twelve in-house real-time PCR assays for detection of Mycoplasma pneumoniae. Diagnostic Microbiology & Infectious Disease, doi: 10.1016/j.diagmicrobio.2017.03.004.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Venor® PCR Quantification Standards

Venor® Quantification Standards for Mycoplasma Detection from Minerva

Minerva Biolabs

Applications

These DNA-Standards allow for the performance of a control reaction for PCR using qPCR instrumentation and to create a standard curve for quantification experiments, i.e. with Venor®Mp Mycoplasma pneumoniae Diagnostic Kit for qPCR. The DNA standards can be used as a general control to confirm PCR system performance using a qPCR instrument or for the validation of detection limits in respect to conventional PCR tests.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.